Product Information
Applications
ApplicationCasein Kinase II Inhibitor I, CAS 17374-26-4, is a cell-permeable, selective, reversible, and ATP/GTP-competitive inhibitor of casein kinase-2 (IC50 = 900 nM for rat liver CK2).
Biological Information
Primary TargetCK2 rat liver, human recombinant
Primary Target IC<sub>50</sub>900 nM and 1.6 µM, using rat liver and human recombinant CK2, respectively; < 1 µM for DYRK1a
Purity≥99% by HPLC
Physicochemical Information
Cell permeableY
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Carcinogenic / Teratogenic
Storage +2°C to +8°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications

Documentation

Casein Kinase II Inhibitor I - CAS 17374-26-4 - Calbiochem SDS

Title

Safety Data Sheet (SDS) 

Casein Kinase II Inhibitor I - CAS 17374-26-4 - Calbiochem Certificates of Analysis

TitleLot Number
218697

References

Reference overview
Borowski, P., et al. 2003. Eur. J. Biochem. 270, 1645.
Sarno, S., et al. 2003. Biochem. J. 374, 639.
Zien, P., et al. 2003. Biochem. Biophys. Res. Commun. 306, 129.
Ruzzene, M., et al. 2002. Biochem. J. 364, 41.
Sarno, S., et al. 2001. FEBS Lett. 496, 44.
Szyszka, R., et al. 1995. Biochem. Biophys. Res. Commun. 208, 418.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision07-January-2009 JSW
SynonymsTBB, TBBt, 4,5,6,7-Tetrabromobenzotriazole, 4,5,6,7-Tetrabromo-2-azabenzimidazole, CK2 Inhibitor
DescriptionA cell-permeable benzotriazolo compound that acts as a highly selective, ATP/GTP-competitive casein kinase II (CKII) inhibitor (IC50 = 900 nM and 1.6 µM for rat liver and human recombinant CKII, respectively) and DYRK (IC50 <1 µM for DYRK1a). Specificity for CKII has been reported following the screening of 33 kinases, including PKA, Akt, PKC, MKK1, ERK2, p38, JNK, Lck, Lyn, and Syk. Also reported to inhibit NS3-associated viral helicase activity in hepatitis C virus (HCV) (IC50 = 20 and 60 µM using DNA and RNA substrates, respectively) and West Nile virus (WNV) (IC50 = 1.7 µM and 900 nM using DNA and RNA substrates, respectively).
FormWhite solid
Intert gas (Yes/No) Packaged under inert gas
CAS number17374-26-4
Chemical formulaC₆HBr₄N₃
Structure formulaStructure formula
Purity≥99% by HPLC
SolubilityDMSO (10 mg/ml)
Storage +2°C to +8°C
Protect from light
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Carcinogenic / Teratogenic
ReferencesBorowski, P., et al. 2003. Eur. J. Biochem. 270, 1645.
Sarno, S., et al. 2003. Biochem. J. 374, 639.
Zien, P., et al. 2003. Biochem. Biophys. Res. Commun. 306, 129.
Ruzzene, M., et al. 2002. Biochem. J. 364, 41.
Sarno, S., et al. 2001. FEBS Lett. 496, 44.
Szyszka, R., et al. 1995. Biochem. Biophys. Res. Commun. 208, 418.

Related Products & Applications

Categories

Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Casein Kinase (CK) Inhibitors